SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-268672
Filing Date
2019-10-17
Accepted
2019-10-16 19:35:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d810316d424b5.htm 424B5 512568
2 GRAPHIC g810316g07z92.jpg GRAPHIC 88080
3 GRAPHIC g810316g59a57.jpg GRAPHIC 34506
4 GRAPHIC g810316g89n71.jpg GRAPHIC 87511
  Complete submission text file 0001193125-19-268672.txt   803009
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-234038 | Film No.: 191153672
SIC: 2834 Pharmaceutical Preparations